1:54 PM
 | 
May 15, 2018
 |  BC Extra  |  Financial News

Arch leads Nohla's $45M series B

Off-the-shelf cell therapy company Nohla Therapeutics Inc. (Seattle, Wash.) raised $45 million in a series B round led by existing investor Arch Venture Partners. Also participating were new investors Fidelity Management and Celgene Corp. (NASDAQ:CELG) and previous investors 5AM Ventures, Alexandria Venture...

Read the full 190 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >